title: Glioblastoma: Part I. Current state of affairs.
abstract: Although uncommon, "brain cancer" is one of the most feared diseases that afflict human beings. While still regarded as one of the most deadly forms of primary brain neoplasm, recent advances in the treatment of glioblastoma (GBM) have offered new hope for patients, families, and clinicians. In the first part of this two-part review, we will focus on the multidisciplinary advances that have established the current treatment approach in the management of GBM. In the second part of this review, ongoing research will be presented including current clinical trials as well as some of the newer technologies that are forming the promise of the future.
authors: Saint Luke's Brain Tumor Center, Kansas City, MO, USA. msalacz@saint-lukes.org
authors: Michael E
authors: ME
authors: Salacz
authors: Kenneth R
authors: KR
authors: Watson
authors: David A
authors: DA
authors: Schomas
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D005909:Glioblastoma / Q000175:diagnosis / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D006801:Humans; D015201:Meta-Analysis as Topic; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology